CTI’s Vonjo Shows Potential In Anemic Myelofibrosis Patients, Promising Further Market Growth

Poses Threat To Other JAK Inhibitors

Person using key to unlock wooden figure
CTI Could Unlock A Bigger Chunk Of The Myelofibrosis Market • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D